Labor Induction: When It Reduces Risk — and When to Think Carefully

When a doctor or midwife recommends inducing labor, most people have one immediate question: Is this actually necessary? It is a fair question. Induction is not a neutral event. It introduces medical interventions, changes the natural course of labor, and carries its own risks — alongside real, evidence-backed benefits in the right circumstances.

Whether you are pregnant, supporting a surrogate through her pregnancy, or trying to understand what your care team is recommending, this guide explains what the research actually shows about labor induction: when it meaningfully reduces risk, when timing should be individualized, and what questions are worth asking before agreeing to proceed.

This article draws on clinical guidance from the American College of Obstetricians and Gynecologists (ACOG) and the World Health Organization (WHO), as well as landmark research published in peer-reviewed medical journals.

What "Induced Labor" Actually Means

Labor induction means using medical methods — medication, mechanical devices, or both — to start uterine contractions before they begin on their own. It is different from augmentation, which strengthens or speeds up labor that has already started spontaneously.

Before any induction begins, providers assess cervical readiness using the Bishop score, a clinical tool that evaluates five factors: how open, thinned, soft, and positioned the cervix is, and how far the baby has descended into the pelvis. Scores range from 0 to 13.

A low Bishop score does not make induction impossible — but it does mean the process will take longer, require more steps, and carry a higher chance of ending in a cesarean delivery if the cervix does not respond.

When the Research Supports Induction

There are clinical scenarios where the evidence for induction is consistent, well-replicated, and genuinely protective.

Pregnancy at 41 weeks and beyond

This is where the research is clearest. Inducing labor at or after 41 weeks reduces the already small absolute risk of perinatal death and stillbirth compared to continued expectant management. A Cochrane systematic review of induction at or beyond term found fewer perinatal deaths, probably fewer cesarean deliveries, and fewer NICU admissions with a policy of induction, without a clear increase in assisted vaginal births. The risk of meconium aspiration syndrome — a serious complication in which the baby inhales stool that has passed into the amniotic fluid — also rises as pregnancy extends beyond term.

The WHO supports offering induction at 41–42 weeks to reduce these risks, even in otherwise uncomplicated pregnancies.

Elective induction at 39 weeks in low-risk patients

The ARRIVE trial, published in the New England Journal of Medicine in 2018, tested elective induction during the 39th week of pregnancy (39+0 to 39+4) in low-risk first-time mothers. The finding challenged widespread assumptions: the induction group had a lower rate of cesarean delivery — 18.6% compared to 22.2% in the expectant management group — and fewer cases of pregnancy-related high blood pressure and preeclampsia. The trial demonstrated that induction does not inherently lead to more cesareans when patient selection is appropriate and clinical protocols allow enough time for labor to progress.

Premature rupture of membranes (PROM) at term

When the amniotic sac breaks before labor begins, the risk of infection for both mother and baby rises with time. ACOG guidelines generally support offering induction promptly in these cases, rather than waiting to see whether labor starts on its own.

Maternal medical conditions

Preeclampsia, gestational hypertension, uncontrolled diabetes, kidney disease, and certain other conditions can make continuing the pregnancy beyond a specific point riskier than delivering. The timing of induction is calibrated to the severity of the condition and the gestational age at which the risk balance shifts.

Certain fetal concerns

Oligohydramnios (too little amniotic fluid), evidence of poor fetal growth, or concerning fetal monitoring results may prompt a recommendation for induction. In cases of suspected fetal macrosomia — a baby estimated to be very large — induction may reduce shoulder dystocia and birth fractures in some studies, but fetal weight estimates are often imprecise and suspected size alone is not usually treated as an automatic reason for early delivery.

When Induction Should Be Individualized

The case for induction is not universal. In a number of scenarios, expectant management — carefully monitoring the pregnancy while waiting for labor to begin naturally — may be reasonable, while induction may still be appropriate if new maternal or fetal concerns develop.

• Uncomplicated pregnancies before 41 weeks: The WHO does not recommend routine induction before 41 weeks when no medical indication exists. For low-risk pregnancies under 41 weeks, induction should be a shared decision rather than a default strategy.
• Well-controlled gestational diabetes: Timing depends on whether diabetes is diet-controlled or medication-controlled, fetal growth, maternal status, and local protocol. It should be individualized rather than treated as an automatic reason for early induction.
• Suspected macrosomia without other risk factors: Professional guidance is cautious about inducing labor based only on an estimated large baby. Ultrasound estimates of fetal weight carry significant margin of error, and the balance of benefit and harm should be discussed case by case.

When Induction Is Not an Option: Absolute Contraindications

Certain conditions make attempting a vaginal delivery — induced or spontaneous — unsafe. In these cases, cesarean delivery is the standard of care, and inducing labor would put the mother or baby at serious risk.

How the Method Changes the Risk Profile

Not all inductions carry the same risks. The method used — and whether the cervix needs ripening before contractions can be stimulated — significantly affects the safety profile and the likelihood of success.

Cervical ripening vs. stimulating contractions

When the Bishop score is low, the cervix must be softened before contractions can be effectively induced. Ripening and stimulation are two distinct steps, often used in sequence.

• Membrane sweeping: A provider separates the amniotic sac from the lower part of the uterus near the cervix, triggering a natural release of prostaglandins that can initiate labor. Often offered at 39–40 weeks. It can reduce the need for formal induction, but causes discomfort and carries a small risk of accidentally rupturing the amniotic sac.
• Balloon catheter (Foley or double-balloon): A catheter is inserted through the cervix and inflated with saline. The steady mechanical pressure encourages gradual dilation. This method is less likely to cause uterine hyperstimulation than medication-based methods and is often considered when cervical ripening is needed in patients attempting a vaginal birth after a prior cesarean (VBAC).
• Prostaglandins (dinoprostone or misoprostol): Medications inserted vaginally or taken orally that soften cervical tissue. Effective at ripening, but they can cause uterine tachysystole — contractions that occur too frequently or last too long — which can reduce oxygen delivery to the baby. Misoprostol must not be used in patients with a prior cesarean delivery or major uterine surgery, due to a substantially elevated risk of uterine rupture.
• Oxytocin (Pitocin): A synthetic hormone given intravenously to stimulate contractions. Used when the cervix is already favorable, or after ripening has been completed. It can also cause tachysystole, so electronic fetal monitoring is typically used throughout oxytocin induction.

The cascade of interventions

One consideration worth naming honestly: some patients experience induced contractions as more intense or less gradual, especially when oxytocin is used. At the same time, large trial data do not show that induction automatically increases epidural use, assisted delivery, or cesarean delivery compared with expectant management. The practical experience depends heavily on the method used, how the hospital manages the early phase of labor, and how much support the patient receives.

How Protocols Vary by Country and System

Protocols vary by institution and country. Always confirm the specific approach with your attending physician.

Questions to Ask Your Medical Team Before Agreeing to Induction

Induction is a medical recommendation — not a mandate. You have the right to understand the reasoning before deciding. These questions are worth raising at any conversation about inducing labor:

1. What is the specific clinical reason for recommending induction now? Ask for the indication — not just that timing has arrived.
2. What is my Bishop score? A score of 5 or below means the cervix is not ready, which affects how long the process will take and the likelihood of a successful vaginal birth.
3. Which method will be used, and why? The choice between a balloon catheter, prostaglandins, and oxytocin carries meaningfully different risk profiles.
4. Do I have a history of cesarean delivery or uterine surgery? If yes, confirm whether misoprostol is being excluded from the plan — it must be.
5. What does expectant management look like as an alternative? What monitoring would be in place if we wait, and what would trigger the decision to act?
6. What are the risks of proceeding — and the risks of not proceeding? Both sides of the decision have a risk profile; you deserve to hear both clearly.
7. How will the baby be monitored during induction? Continuous electronic fetal monitoring is standard once induction begins.
8. At what point would induction be considered unsuccessful, and what happens next? Understanding the threshold for a cesarean delivery helps set realistic expectations.

For Surrogacy Journeys: How Delivery Decisions Are Made

In a gestational surrogacy arrangement, the surrogate carries the pregnancy and is the patient in the clinical relationship. All medical decisions — including whether and when to induce labor — rest with her and her obstetric team. Intended parents are not the decision-makers in this context, and neither is the agency.

That said, intended parents have legitimate questions about how delivery is planned and how they will be kept informed throughout. In a well-coordinated surrogacy journey, the agency acts as a communication bridge: ensuring that intended parents understand what is happening and why, without overriding the surrogate's medical autonomy or her relationship with her doctors.

The factors that may lead to an induction recommendation in a surrogate pregnancy are the same as in any pregnancy — gestational age reaching 41 weeks, premature rupture of membranes, blood pressure changes, or fetal monitoring findings that indicate delivery is safer than waiting. These decisions are managed by the obstetric team according to established clinical protocols.

If you are working with a surrogate and have questions about how delivery is planned, the right step is to raise them with your agency coordinator — who can communicate with the medical team and make sure your questions are addressed clearly and promptly.

How Delivering Dreams Supports You Through Delivery

At Delivering Dreams, we coordinate closely with our partner clinics throughout the entire pregnancy — and delivery planning is part of that coordination from early on. Our team stays in regular contact with the surrogate's medical team, and intended parents receive updates in English after every key milestone: clinic visits, ultrasounds, and any discussions about delivery timing.

We do not make medical decisions — those belong to the surrogate and her physicians. What we do is make sure you understand what is happening and what questions are available to you. Our experience coordinating deliveries in Lviv and Kyiv means we know the protocols, the facilities, and the standards of care our families should expect.

Our delivery-period coordination includes:

• Regular updates from surrogate clinic visits, translated into English
• Clear guidance on when to travel to Ukraine and what to expect at the maternity hospital
• Communication support between intended parents and the medical team
• Full documentation support for the birth certificate and legal exit process immediately after birth

To understand what the full journey looks like — from surrogate match to birth — visit our surrogacy timeline estimator. For a detailed overview of what our programs include, see our surrogacy in Ukraine page.